AKARI THERAPEUTICS PLC-ADR (AKTX)

US00972G2075 - ADR

1.185  0 (-0.42%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
16.81M23.09M17.21M17.98M16.96M
Research and Development
8.02M11.88M12.20M12.19M16.65M
Selling, General, and Administrative Expenses
11.36M13.53M8.08M9.16M8.22M
Operating Income
-16.81M-23.09M-17.21M-17.98M-16.96M
Interest Income/Expense
218.00K-1.46M-180.00K360.00K-60.00K
Other Income/Expense
6.58M6.80M-30.00K530.00K180.00K
Non Recurring Items
N/AN/AN/A0.000.00
Income Before Taxes
-10.01M-17.75M-17.42M-17.08M-16.85M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-10.01M-17.75M-17.42M-17.08M-16.85M
EBITDA
-16.80MN/AN/A-17.97M-16.94M
 
Per Share Data
EPS Diluted Total Ops
-1.260.000.00-12.35-12.35
Non GAAP EPS
N/AN/AN/AN/A-0.93
 
Statistics

All data in USD

Charts